Homogenous NAD assay for ARDT activity measurement
Homogenous NAD assay for ARDT activity measurement
批准号:
8735970
负责人:
Karen Wu
金额:
$8.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-18 至 2015-12-31
关键词:
ADP Ribose TransferasesAffectAppearanceBasic ScienceBindingBiological AssayCharacteristicsCollaborationsDevelopmentDiabetes MellitusDrug IndustryEnsureEnzymatic BiochemistryEnzymesFamilyFluorescenceFluorescence Resonance Energy TransferInflammationLegal patentMalignant NeoplasmsMeasurementMeasuresMetabolic syndromeMetabolismMethodsMitochondriaNiacinamideNicotinamide adenine dinucleotideNon-Insulin-Dependent Diabetes MellitusObesityPeptidesPerformancePhaseProcessRNAReactionRelative (related person)ResearchSamplingSignal TransductionSirtuinsSmall Business Innovation Research GrantSpinach - dietarySystemTechnologyTestingTimeaptamerbasecommercializationdrug discoveryenzyme activityinterestnovelpublic health relevanceresearch studyscreeningsensortool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Sirtuins and ADP ribosyltransferases (ARDTs) are two families of related enzymes that have important medically relevant functions. For example, SIRT3, a mitochondrial sirtuin, controls mitochondrial function, and thereby exerts a strong effect on metabolism, obesity, type 2 diabetes, and metabolic syndrome. There is a major need to have simple assays to measure the activity of SIRT3, as well as other sirtuins and their close relatives, the ARDTs. Each of these enzymes uses nicotinamide adenine dinucleotide (NAD), and generates nicotinamide as a byproduct of these reactions. Unfortunately, current methods for assaying the activity of these enzymes are not optimal because they are not homogeneous, are not continuous, lack sensitivity, and often not generalizable to screening all of the diverse enzymes that generate nicotinamide. A more straightforward assay would be to directly measure the products of these enzymes in a homogeneous format. Therefore, assays that directly detect the appearance of nicotinamide would be useful for measuring the activity these enzymes, regardless of the specific substrate. Using a patented sensor technology developed by Lucerna, we will develop a universal sirtuin/ARDT assay based on a simple, homogeneous fluorescence sensor that is highly specific for nicotinamide. This Phase I SBIR application describes proof-of-concept experiments for developing, characterizing, and optimizing our nicotinamide sensors in an assay for SIRT3 activity. For Phase II, our assay will be optimized to comply with standards required for ensuring that this assay can be packaged and used in a kit format for a variety of sirtuins and related enzymes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fluorescent reporters for real-time single-cell Pol III transcription measurement
-
批准号:9254931
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2017
-
负责人:Karen Wu
-
依托单位:
Fluorescent RNA foci assay for FXTAS drug discovery
-
批准号:8647780
-
项目类别:
-
资助金额:$20.79万
-
财政年份:2014
-
负责人:Karen Wu
-
依托单位:
Homogenous NAD assay for ARDT activity measurement
-
批准号:8591776
-
项目类别:
-
资助金额:$21.18万
-
财政年份:2013
-
负责人:Karen Wu
-
依托单位:
New toolkit to visualize RNAs in living cells
-
批准号:8315429
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:Karen Wu
-
依托单位:
New toolkit to visualize RNAs in living cells
-
批准号:8878350
-
项目类别:
-
资助金额:$50.75万
-
财政年份:2012
-
负责人:Karen Wu
-
依托单位:
New toolkit to visualize RNAs in living cells
-
批准号:8647672
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2012
-
负责人:Karen Wu
-
依托单位:
Clozapine Sensors for Improving Therapeutic Treatments of Schizophrenia
-
批准号:8200324
-
项目类别:
-
资助金额:$32.86万
-
财政年份:2011
-
负责人:Karen Wu
-
依托单位:
海外基金